Harwell Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -47.21%
- Profit Growth -372.91%
- Ebitda -1014.03%
- Net Worth -23.97%
- Total Assets -41.46%
About Harwell Lifesciences
Harwell Lifesciences Private Limited (HLPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 March 2017 (Seven years and ten months 23 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Maliyekal Shamsudeen, Nahas Hameed, Rahmabeevi, and Two other members serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999KA2017PTC101267
-
Company No.
101267
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Mar 2017
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Harwell Lifesciences?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maliyekal Shamsudeen
|
Director | 10-Mar-2017 | Current |
|
Nahas Hameed
|
Director | 10-Mar-2017 | Current |
|
Rahmabeevi
|
Director | 10-Mar-2017 | Current |
|
Urikkunnath Kunhu
|
Director | 10-Mar-2017 | Current |
|
Paul Varghese
|
Director | 10-Mar-2017 | Current |
Financial Performance of Harwell Lifesciences.
Harwell Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 47.21% decrease. The company also saw a substantial fall in profitability, with a 372.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Harwell Lifesciences?
In 2019, Harwell Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Harwell Lifesciences?
Unlock and access historical data on people associated with Harwell Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harwell Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harwell Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.